Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONCE

Spark Therapeutics (ONCE) Stock Price, News & Analysis

Spark Therapeutics logo

About Spark Therapeutics Stock (NASDAQ:ONCE)

Advanced Chart

Key Stats

Today's Range
$0.18
$0.18
50-Day Range
$110.05
$113.57
52-Week Range
$34.53
$114.20
Volume
N/A
Average Volume
891,560 shs
Market Capitalization
$6.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spark Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ONCE Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

ONCE Stock Analysis - Frequently Asked Questions

Spark Therapeutics Inc (NASDAQ:ONCE) posted its quarterly earnings results on Tuesday, August, 7th. The biotechnology company reported ($0.77) earnings per share for the quarter, missing analysts' consensus estimates of ($0.43) by $0.34. The biotechnology company had revenue of $25.19 million for the quarter, compared to analysts' expectations of $29.44 million. Spark Therapeutics had a negative trailing twelve-month return on equity of 59.10% and a negative net margin of 358.41%.

Spark Therapeutics (ONCE) raised $88 million in an IPO on Friday, January 30th 2015. The company issued 5,500,000 shares at $15.00-$17.00 per share. J.P. Morgan and Credit Suisse acted as the underwriters for the IPO and Cowen and Company and Sanford C. Bernstein were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spark Therapeutics investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Brainstorm Cell Therapeutics (BCLI), Meta Platforms (META), Alibaba Group (BABA), Gilead Sciences (GILD) and Micron Technology (MU).

Company Calendar

Last Earnings
8/07/2018
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ONCE
Fax
N/A
Employees
368
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.82 million
Net Margins
-358.41%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$64.72 million
Price / Cash Flow
N/A
Book Value
$13.15 per share
Price / Book
0.01

Miscellaneous

Free Float
N/A
Market Cap
$6.94 million
Optionable
No Data
Beta
2.05
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ONCE) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners